Discovery, Identification, and Characterization of Candidate Pharmacodynamic Markers of Methionine Aminopeptidase-2 Inhibition
- 2 October 2008
- journal article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 7 (11), 4807-4820
- https://doi.org/10.1021/pr800388p
Abstract
The catalytic activity of methionine aminopeptidase-2 (MetAP2) has been pharmacologically linked to cell growth, angiogenesis, and tumor progression, making this an attractive target for cancer therapy. An assay for monitoring specific protein changes in response to MetAP2 inhibition, allowing pharmacokinetic (PK)/pharmacodynamic (PD) models to be established, could dramatically improve clinical decision-making. Candidate MetAP2-specific protein substrates were discovered from undigested cell culture-derived proteomes by MALDI-/SELDI-MS profiling and a biochemical method using 35S-Met labeled protein lysates. Substrates were identified either as intact proteins by FT-ICR-MS or applying in-gel protease digestions followed by LC-MS/MS. The combination of these approaches led to the discovery of novel MetAP2-specific substrates including thioredoxin-1 (Trx-1), SH3 binding glutamic acid rich-like protein (SH3BGRL), and eukaryotic elongation factor-2 (eEF2). These studies also confirmed glyceraldehye 3-phosphate dehydrogenase (GAPDH) and cyclophillin A (CypA) as MetAP2 substrates. Additional data in support of these proteins as MetAP2-specific substrates were provided by in vitro MetAP1/MetAP2 enzyme assays with the corresponding N-terminal derived peptides and 1D/2D Western analyses of cellular and tissue lysates. FT-ICR-MS characterization of all intact species of the 18 kDa substrate, CypA, enabled a SELDI-MS cell-based assay to be developed for correlating N-terminal processing and inhibition of proliferation. The MetAP2-specific protein substrates discovered in this study have diverse properties that should facilitate the development of reagents for testing in preclinical and clinical environments.Keywords
This publication has 53 references indexed in Scilit:
- Identification of Specific Protein Markers in Microdissected Hepatocellular CarcinomaJournal of Proteome Research, 2006
- Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancerBiochemical and Biophysical Research Communications, 2006
- Serum Proteomic Profiling by Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry for Cancer Diagnosis: Next StepsCancer Research, 2006
- The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transductionProceedings of the National Academy of Sciences, 2006
- Classification of cancer types by measuring variants of host response proteins using SELDI serum assaysInternational Journal of Cancer, 2005
- Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?Clinical Chemistry, 2003
- N‐terminal methionine removal and methionine metabolism in Saccharomyces cerevisiaeJournal of Cellular Biochemistry, 2003
- The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two‐dimensional electrophoresis gels and identification of 325 distinct proteinsProteomics, 2003
- Serum Proteomic Patterns for Detection of Prostate CancerJNCI Journal of the National Cancer Institute, 2002
- Hb Long Island: a hemoglobin variant with a methionyl extension at the NH2 terminus and a prolyl substitution for the normal histidyl residue 2 of the beta chain.Proceedings of the National Academy of Sciences, 1985